Top Story

FDA approves Brineura for type of Batten disease

April 28, 2017

The FDA has approved cerliponase alfa to curb the loss of ambulation among patients aged 3 years and older diagnosed with late infantile neuronal ceroid lipofuscinosis type 2, an extremely rare and fatal autosomal recessive neurodegenerative disorder, also known as Batten disease.

One of a group of disorders known as neuronal ceroid lipofuscinoses, collectively referred to as Batten disease, ceroid lipofuscinosis type 2 (CLN2) primarily affects the nervous system, with initial symptoms including language delays, epilepsy and ataxia, as well as later symptoms of myoclonus and vision loss. In the late infantile form of the disease, signs and symptoms typically manifest between ages 2 and 4 years.


CDC: Yellow fever vaccine supply to be depleted in US by mid-2017

April 28, 2017
The CDC announced today that it is anticipating a complete depletion of the U.S. supply of YF-VAX — the only yellow fever vaccine licensed in the United States…
In the Journals

Fast-food ads drive eating choices for preschoolers

April 28, 2017
Children who watch fast-food advertising are more likely to consume the food being advertised, suggesting that parents may need assistance in determining the risks of…

Dasotraline improves ADHD outcomes in the classroom

April 28, 2017
Recent findings indicated dasotraline, a dopamine and norepinephrine reuptake inhibitor, significantly improved ADHD outcomes in the classroom among children aged 6 to…

US- and foreign-born teens show comparable vaccination rates

April 28, 2017
ATLANTA — Teenagers who were born in a country other than the United States were shown to have comparable vaccination coverage rates when compared with U.S.-born
More News Headlines »
Original ResearchOpen Access

Validating Health Literacy and Numeracy Measures in Minority Groups

HLRP: Health Literacy Research and Practice, Spring 2017, Volume 1 Issue 2
Validation studies of existing health literacy or numeracy tools among racial/ethnic minorities are limited. This study…
More »

HPV Immunization: Ensuring Your Patients Do Not Slip through the Cracks

This activity is supported by an educational grant from Merck & Co., Inc.

Vaccination rates for the human papillomavirus (HPV) continue to be below those of other vaccines recommended for…
More »
American Academy of Allergy, Asthma & Immunology Annual Meeting

American Academy of Allergy, Asthma & Immunology Annual Meeting

Meeting News

VIDEO: Anthony Fauci, MD, discusses progress with malaria vaccine

April 3, 2017
More »